首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >FORMULATION AND CHARACTERIZATION OF CARVEDILOL NANOEMULSION ORAL LIQUID DOSAGE FORM
【24h】

FORMULATION AND CHARACTERIZATION OF CARVEDILOL NANOEMULSION ORAL LIQUID DOSAGE FORM

机译:卡维地洛纳米乳口服液的剂型设计与表征

获取原文
           

摘要

Objective: Carvedilol is antihypertensive. It is practically water insoluble. Therefore, the objective of this investigation is a formulation and characterization of carvedilol nano emulsion (NE) employing orally to increase carvedilol solubility for enhancing of carvedilol bioavailability. Methods: The formulation components were chosen according to the solubility study. The diagrams of pseudo-ternary phase were made using the aqueous phase titration method. The formulated nanoemulsions were subjected to various thermodynamic stability assays. We selected eight of formulas that have thermodynamic stability for further optimization for various characterizations in order to select the best formula. Results: The carvedilol NE3 considered a selected formula. It composes of 1.25 mg carvedilol per g of the nanoemulsion, 10 % of peppermint oil, 20% of tween80, 10% ethanol and 60% of distilled water. It was characterized by a low globule size range, low poly dispersity index, higher zeta potential, good pH value, efficient electroconductivity, classy percent of light transmittance, higher % drug content, acceptable low viscosity and carvedilol release was significantly higher (P<0.05) in dissolution rate. The carvedilol NE3 subject for further investigations. Fourier transformed infrared spectroscopy confirm no incompatibility between the drug and excipients. The atomic force microscopy study shows that system in nanoscale and has high stability. Conclusion: The selected formula (carvedilol NE3) was a promising nanoemulsion formula that increases the carvedilol solubility result in an increment of its bioavailability. Keywords: Nanoemulsion, Carvedilol, Solubility studies, Peudoternary phase diagrams.
机译:目的:卡维地洛具有降压作用。它实际上是水不溶性的。因此,本研究的目的是配制和表征卡维地洛纳米乳剂(NE),其口服使用以增加卡维地洛的溶解度以增强卡维地洛的生物利用度。方法:根据溶解度研究选择配方成分。使用水相滴定法绘制假三元相图。对配制的纳米乳剂进行各种热力学稳定性测定。我们选择了八个具有热力学稳定性的公式,以进一步优化各种特性,以选择最佳公式。结果:卡维地洛NE3考虑了选定的配方。每克纳米乳液含有1.25毫克卡维地洛,10%的薄荷油,20%的tween80、10%乙醇和60%的蒸馏水。它的特点是小球尺寸范围低,多分散指数低,zeta电位高,pH值高,有效电导率,透光率高,透光率高,药物含量高,可接受的低粘度和卡维地洛释放明显更高(P <0.05 )的溶出度。卡维地洛NE3主题尚待进一步研究。傅立叶变换红外光谱法确认药物与赋形剂之间没有不相容性。原子力显微镜研究表明,该系统在纳米级具有很高的稳定性。结论:选定的配方(卡维地洛NE3)是一种有前途的纳米乳配方,可增加卡维地洛的溶解度,从而增加其生物利用度。关键词:纳米乳液,卡维地洛,溶解度研究,伪三元相图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号